Atypical Wells syndrome successfully treated with dupilumab

Abstract Wells syndrome, also referred to as eosinophilic cellulitis, is a rare and often sporadic inflammatory skin condition whose aetiology remains uncertain. Clinically, this condition presents as a collection of erythematous, oedematous, and tender skin lesions most often affecting the extremit...

Full description

Bibliographic Details
Main Authors: Patrick McMullan, Kristin Torre, Sueheidi Santiago, Gillian Weston, Jun Lu
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Skin Health and Disease
Online Access:https://doi.org/10.1002/ski2.206
_version_ 1797814378421026816
author Patrick McMullan
Kristin Torre
Sueheidi Santiago
Gillian Weston
Jun Lu
author_facet Patrick McMullan
Kristin Torre
Sueheidi Santiago
Gillian Weston
Jun Lu
author_sort Patrick McMullan
collection DOAJ
description Abstract Wells syndrome, also referred to as eosinophilic cellulitis, is a rare and often sporadic inflammatory skin condition whose aetiology remains uncertain. Clinically, this condition presents as a collection of erythematous, oedematous, and tender skin lesions most often affecting the extremities and trunk that can mimic cellulitis. Histologically, Wells syndrome is characterised by inflammatory changes and eosinophilic infiltration of the dermis with the absence of underlying infection, thereby distinguishing it from cellulitis. Due to the rarity of this syndrome and its ambiguous presentation, there remains to be a definitive strategy for treatment. Recent case reports have documented varying success and recurrence with the use of oral and topical corticosteroids, antifungals, antibiotics, immunosuppressants and antihistamines. Here, we report a unique case of progressively worsening neutrophilic‐rich Wells syndrome on the vertex of the scalp that was successfully treated with a combination of dupilumab and oral corticosteroids.
first_indexed 2024-03-13T08:05:47Z
format Article
id doaj.art-f124c6bdd58b434abcf79e89f5e0ff43
institution Directory Open Access Journal
issn 2690-442X
language English
last_indexed 2024-03-13T08:05:47Z
publishDate 2023-06-01
publisher Wiley
record_format Article
series Skin Health and Disease
spelling doaj.art-f124c6bdd58b434abcf79e89f5e0ff432023-06-01T05:13:40ZengWileySkin Health and Disease2690-442X2023-06-0133n/an/a10.1002/ski2.206Atypical Wells syndrome successfully treated with dupilumabPatrick McMullan0Kristin Torre1Sueheidi Santiago2Gillian Weston3Jun Lu4Department of Dermatology University of Connecticut Health Center Farmington Connecticut USADepartment of Dermatology University of Connecticut Health Center Farmington Connecticut USADepartment of Dermatology University of Connecticut Health Center Farmington Connecticut USADepartment of Dermatology University of Connecticut Health Center Farmington Connecticut USADepartment of Dermatology University of Connecticut Health Center Farmington Connecticut USAAbstract Wells syndrome, also referred to as eosinophilic cellulitis, is a rare and often sporadic inflammatory skin condition whose aetiology remains uncertain. Clinically, this condition presents as a collection of erythematous, oedematous, and tender skin lesions most often affecting the extremities and trunk that can mimic cellulitis. Histologically, Wells syndrome is characterised by inflammatory changes and eosinophilic infiltration of the dermis with the absence of underlying infection, thereby distinguishing it from cellulitis. Due to the rarity of this syndrome and its ambiguous presentation, there remains to be a definitive strategy for treatment. Recent case reports have documented varying success and recurrence with the use of oral and topical corticosteroids, antifungals, antibiotics, immunosuppressants and antihistamines. Here, we report a unique case of progressively worsening neutrophilic‐rich Wells syndrome on the vertex of the scalp that was successfully treated with a combination of dupilumab and oral corticosteroids.https://doi.org/10.1002/ski2.206
spellingShingle Patrick McMullan
Kristin Torre
Sueheidi Santiago
Gillian Weston
Jun Lu
Atypical Wells syndrome successfully treated with dupilumab
Skin Health and Disease
title Atypical Wells syndrome successfully treated with dupilumab
title_full Atypical Wells syndrome successfully treated with dupilumab
title_fullStr Atypical Wells syndrome successfully treated with dupilumab
title_full_unstemmed Atypical Wells syndrome successfully treated with dupilumab
title_short Atypical Wells syndrome successfully treated with dupilumab
title_sort atypical wells syndrome successfully treated with dupilumab
url https://doi.org/10.1002/ski2.206
work_keys_str_mv AT patrickmcmullan atypicalwellssyndromesuccessfullytreatedwithdupilumab
AT kristintorre atypicalwellssyndromesuccessfullytreatedwithdupilumab
AT sueheidisantiago atypicalwellssyndromesuccessfullytreatedwithdupilumab
AT gillianweston atypicalwellssyndromesuccessfullytreatedwithdupilumab
AT junlu atypicalwellssyndromesuccessfullytreatedwithdupilumab